Received May 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Clinic only gave the Men B component to the patient. They did not mix it with the Men ACWY component; Clinic only gave the Men B component to the patient. They did not mix it with the Men ACWY component; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ABCWY NVS (Penmenvy) for prophylaxis. On an unknown date, the patient received Penmenvy. On an unknown date, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: Clinic only gave the Men B component to the patient. They did not mix it with the Men ACWY component) and inappropriate dose of vaccine administered (Verbatim: Clinic only gave the Men B component to the patient. They did not mix it with the Men ACWY component). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-MAY-2026 The patient only received the Men B portion of Penmenvy. The batch number was not provided and a request for this information has been made.